Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

PRP is more effective than triamcinolone for treating alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Tofacitinib, a hair regrowth treatment, may worsen acne.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

JAK inhibitors show promise for treating various skin diseases.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Tofacitinib treatment for hair loss may worsen acne.

Different doses of triamcinolone injections work equally well for skin conditions.